Scolioscan provides AI 3D ultrasound imaging technology, equipment and solutions.
Scolioscan has raised $2.5M in total funding. The most recent round was Seed. The last funding was announced in April 2024.
Scolioscan's investors include Fosun Pharma, The Hong Kong Polytechnic University, AEF Greater Bay Area Fund.
Scolioscan is headquartered in New Territories, Hong Kong.
Scolioscan provides AI 3D ultrasound imaging technology, equipment and solutions.
Scolioscan is at the Seed stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Scolioscan — Funding & Investors." VCBacked, April 25, 2024, https://www.vcbacked.co/company/scolioscan. Accessed August 14, 2026.
VCBacked. (2024). Scolioscan — Funding & Investors. Retrieved August 14, 2026, from https://www.vcbacked.co/company/scolioscan
{{cite web |title=Scolioscan — Funding & Investors |url=https://www.vcbacked.co/company/scolioscan |website=VCBacked |access-date=August 14, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated